Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

NCT01851330 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

647

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C Virus

Interventions

DRUG: LDV/SOF
DRUG: RBV

Sponsor

Gilead Sciences